The hospital lobby is asking federal officials to head off expanded data collection policies some drugmakers are implementing for providers participating in the 340B drug discount program.

The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more ...

Washingtonians are struggling to afford already high health care costs, and those costs keep climbing. Sadly, I’ve seen this ...

A new Ohio bill won't expand the 340B program, but it will protect patients' ability to fill prescriptions at their pharmacy of choice.

A new report paints a stark picture of how a subset of large healthcare providers are drawing the lion’s share of 340B savings within a single state.  | A Minnesota analysis of providers' reported ...

AHA letter to the Health Resources and Services Administration about a new concerning development with the 340B Program.

The Washington state House Appropriations Committee has advanced a bill concerning a federal drug pricing program known as ...

When it was passed in 1992, no one thought to mandate how hospitals and clinics would spend the deep discounts they receive on prescription drugs.

The 340B program requires pharmaceutical manufacturers to sell drugs at significant discounts — in some cases, extremely steep discounts — to hospitals and clinics serving large numbers of uninsured ...

The drug discount program is under scrutiny on a variety of fronts ...

Hospitals and contract pharmacies are not required to pass those savings directly to patients at the pharmacy counter. | ...

The original goal of the 340B drug discount program was to allow qualified providers to “stretch federal resources as far as possible reaching more eligible patients and providing more comprehensive ...